The Emergence of new-onset SLE following SARS-CoV-2 vaccination
QJM
.
2021 Dec 20;114(10):739-740.
doi: 10.1093/qjmed/hcab229.
Authors
A Nune
1
,
K P Iyengar
2
,
P Ish
3
,
B Varupula
4
,
C A Musat
5
,
H R Sapkota
6
Affiliations
1
From the Department of Rheumatology, Southport and Ormskirk NHS Trust, Southport, UK. PR8 6PN.
2
Department of Trauma and Orthopaedics, Southport and Ormskirk NHS Trust, UK, PR8 6PN.
3
Department of Pulmonary and Critical Care Medicine, VMMC and Safdarjung Hospital, Delhi 110029, India.
4
Department of Endocrinology, Southport and Ormskirk NHS Trust, Southport, UK, PR8 6PN.
5
Department of Medicine, Southport and Ormskirk NHS Trust, Southport, UK. PR8 6PN.
6
Department of Rheumatology, The Royal Wolverhampton NHS Trust, UK, WV10 0QP.
PMID:
34450645
DOI:
10.1093/qjmed/hcab229
No abstract available
Publication types
Case Reports
MeSH terms
COVID-19 Vaccines / adverse effects*
COVID-19* / prevention & control
Humans
Lupus Erythematosus, Systemic* / chemically induced
Male
Vaccination / adverse effects
Young Adult
Substances
COVID-19 Vaccines